Concepts (314)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 28 | 2025 | 1017 | 4.140 |
Why?
|
| Healthy Lifestyle | 9 | 2024 | 35 | 3.380 |
Why?
|
| Cardiovascular Diseases | 16 | 2025 | 340 | 3.260 |
Why?
|
| Alzheimer Disease | 12 | 2025 | 1962 | 2.380 |
Why?
|
| Obesity | 10 | 2020 | 290 | 2.360 |
Why?
|
| Life Expectancy | 8 | 2020 | 18 | 2.300 |
Why?
|
| Diet, Mediterranean | 10 | 2024 | 90 | 2.290 |
Why?
|
| Body Mass Index | 13 | 2024 | 419 | 1.840 |
Why?
|
| Aged | 61 | 2025 | 8501 | 1.780 |
Why?
|
| Prospective Studies | 30 | 2025 | 1633 | 1.620 |
Why?
|
| Exercise | 13 | 2022 | 422 | 1.580 |
Why?
|
| Female | 65 | 2025 | 14273 | 1.560 |
Why?
|
| Apolipoprotein E4 | 8 | 2025 | 244 | 1.560 |
Why?
|
| Risk Factors | 30 | 2025 | 2224 | 1.510 |
Why?
|
| Humans | 89 | 2025 | 25692 | 1.490 |
Why?
|
| Male | 57 | 2025 | 13917 | 1.470 |
Why?
|
| Netherlands | 18 | 2024 | 23 | 1.380 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2024 | 177 | 1.360 |
Why?
|
| Cognition | 15 | 2024 | 1265 | 1.320 |
Why?
|
| Independent Living | 6 | 2025 | 294 | 1.170 |
Why?
|
| Pediatric Obesity | 2 | 2018 | 41 | 1.150 |
Why?
|
| Aging | 11 | 2025 | 1429 | 1.140 |
Why?
|
| Mothers | 2 | 2018 | 172 | 1.040 |
Why?
|
| Stroke | 5 | 2023 | 259 | 1.020 |
Why?
|
| Cohort Studies | 20 | 2025 | 1781 | 1.000 |
Why?
|
| Neurodegenerative Diseases | 6 | 2025 | 117 | 0.950 |
Why?
|
| Chicago | 16 | 2025 | 869 | 0.920 |
Why?
|
| Waist Circumference | 4 | 2016 | 35 | 0.890 |
Why?
|
| Aged, 80 and over | 23 | 2025 | 4459 | 0.860 |
Why?
|
| Middle Aged | 30 | 2024 | 8403 | 0.830 |
Why?
|
| Vitamin D | 2 | 2022 | 40 | 0.830 |
Why?
|
| DNA Methylation | 6 | 2021 | 139 | 0.810 |
Why?
|
| Dementia | 6 | 2024 | 532 | 0.800 |
Why?
|
| Risk Assessment | 7 | 2024 | 618 | 0.760 |
Why?
|
| Overweight | 5 | 2021 | 74 | 0.740 |
Why?
|
| Epigenomics | 4 | 2021 | 13 | 0.730 |
Why?
|
| Blood Pressure | 3 | 2024 | 185 | 0.730 |
Why?
|
| Longitudinal Studies | 10 | 2025 | 1300 | 0.720 |
Why?
|
| Menopause | 5 | 2024 | 92 | 0.710 |
Why?
|
| Dietary Approaches To Stop Hypertension | 4 | 2024 | 31 | 0.660 |
Why?
|
| Brain | 6 | 2024 | 1560 | 0.650 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2018 | 1 | 0.620 |
Why?
|
| Incidence | 9 | 2025 | 731 | 0.620 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 25 | 0.610 |
Why?
|
| Metabolic Syndrome | 2 | 2016 | 60 | 0.610 |
Why?
|
| Mortality | 2 | 2016 | 80 | 0.610 |
Why?
|
| Preconception Care | 1 | 2018 | 1 | 0.600 |
Why?
|
| Patient Compliance | 1 | 2018 | 148 | 0.560 |
Why?
|
| Lipids | 3 | 2025 | 50 | 0.550 |
Why?
|
| Biomarkers | 8 | 2025 | 554 | 0.540 |
Why?
|
| Neurofilament Proteins | 3 | 2025 | 17 | 0.540 |
Why?
|
| United States | 8 | 2024 | 1943 | 0.530 |
Why?
|
| Proportional Hazards Models | 8 | 2024 | 332 | 0.530 |
Why?
|
| Obesity, Metabolically Benign | 1 | 2016 | 1 | 0.530 |
Why?
|
| Body Composition | 1 | 2016 | 57 | 0.510 |
Why?
|
| Anthropometry | 1 | 2015 | 36 | 0.490 |
Why?
|
| tau Proteins | 3 | 2025 | 219 | 0.490 |
Why?
|
| Alleles | 4 | 2024 | 190 | 0.490 |
Why?
|
| Somatotypes | 1 | 2014 | 2 | 0.480 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 1689 | 0.440 |
Why?
|
| Postmenopause | 3 | 2018 | 53 | 0.400 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 264 | 0.400 |
Why?
|
| Carotid Intima-Media Thickness | 3 | 2022 | 17 | 0.390 |
Why?
|
| Risk Reduction Behavior | 4 | 2020 | 39 | 0.380 |
Why?
|
| Environmental Exposure | 2 | 2024 | 17 | 0.380 |
Why?
|
| Diet | 5 | 2024 | 207 | 0.380 |
Why?
|
| Air Pollution | 2 | 2024 | 12 | 0.370 |
Why?
|
| Adult | 11 | 2024 | 7336 | 0.370 |
Why?
|
| CpG Islands | 4 | 2021 | 43 | 0.370 |
Why?
|
| Alcohol Drinking | 4 | 2020 | 72 | 0.370 |
Why?
|
| White Matter | 2 | 2022 | 123 | 0.360 |
Why?
|
| Atherosclerosis | 3 | 2022 | 55 | 0.360 |
Why?
|
| Life Style | 3 | 2022 | 172 | 0.350 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 351 | 0.330 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 1077 | 0.330 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 77 | 0.310 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 80 | 0.310 |
Why?
|
| Pandemics | 2 | 2020 | 227 | 0.300 |
Why?
|
| Apolipoproteins E | 4 | 2023 | 226 | 0.300 |
Why?
|
| Population Surveillance | 2 | 2021 | 103 | 0.300 |
Why?
|
| Intermediate Filaments | 3 | 2023 | 20 | 0.300 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2025 | 42 | 0.300 |
Why?
|
| Coronary Disease | 2 | 2018 | 56 | 0.300 |
Why?
|
| Body Size | 2 | 2019 | 13 | 0.290 |
Why?
|
| Dietary Supplements | 3 | 2022 | 62 | 0.280 |
Why?
|
| Lipid Metabolism | 2 | 2017 | 36 | 0.280 |
Why?
|
| Adolescent | 4 | 2024 | 2076 | 0.280 |
Why?
|
| Child | 3 | 2024 | 1277 | 0.270 |
Why?
|
| Estrogen Receptor beta | 2 | 2016 | 5 | 0.260 |
Why?
|
| Prevalence | 3 | 2023 | 435 | 0.260 |
Why?
|
| Sex Factors | 5 | 2020 | 427 | 0.250 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 75 | 0.250 |
Why?
|
| Waist-Hip Ratio | 2 | 2015 | 14 | 0.250 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 315 | 0.240 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 126 | 0.240 |
Why?
|
| Coffee | 1 | 2024 | 3 | 0.240 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.240 |
Why?
|
| Beverages | 1 | 2024 | 11 | 0.240 |
Why?
|
| Air Pollutants | 1 | 2024 | 11 | 0.240 |
Why?
|
| Particulate Matter | 1 | 2024 | 17 | 0.240 |
Why?
|
| Social Isolation | 1 | 2025 | 29 | 0.240 |
Why?
|
| Loneliness | 1 | 2025 | 61 | 0.230 |
Why?
|
| Weight Gain | 3 | 2024 | 62 | 0.220 |
Why?
|
| Dietary Fats | 1 | 2024 | 34 | 0.220 |
Why?
|
| Whole Grains | 1 | 2023 | 7 | 0.220 |
Why?
|
| Florida | 1 | 2023 | 20 | 0.220 |
Why?
|
| Memory Disorders | 1 | 2024 | 160 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 259 | 0.210 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2022 | 2 | 0.210 |
Why?
|
| Vitamin E | 1 | 2023 | 39 | 0.210 |
Why?
|
| Flavonols | 1 | 2022 | 11 | 0.210 |
Why?
|
| Betacoronavirus | 2 | 2020 | 65 | 0.200 |
Why?
|
| Vitamins | 1 | 2022 | 19 | 0.200 |
Why?
|
| Time Factors | 7 | 2021 | 1336 | 0.200 |
Why?
|
| Smoking | 3 | 2020 | 165 | 0.200 |
Why?
|
| Lutein | 1 | 2021 | 5 | 0.190 |
Why?
|
| Zeaxanthins | 1 | 2021 | 5 | 0.190 |
Why?
|
| Carotenoids | 1 | 2021 | 14 | 0.190 |
Why?
|
| Survivors | 1 | 2022 | 67 | 0.190 |
Why?
|
| Lipoproteins, HDL | 1 | 2021 | 24 | 0.190 |
Why?
|
| Diet Surveys | 1 | 2021 | 26 | 0.190 |
Why?
|
| Leukocytes | 1 | 2021 | 35 | 0.190 |
Why?
|
| Health Status | 2 | 2019 | 209 | 0.190 |
Why?
|
| Diet, Western | 1 | 2021 | 11 | 0.180 |
Why?
|
| Body Weight | 2 | 2018 | 137 | 0.180 |
Why?
|
| Weight Loss | 2 | 2020 | 105 | 0.180 |
Why?
|
| Nurses | 2 | 2018 | 50 | 0.180 |
Why?
|
| Amyloid | 1 | 2021 | 50 | 0.180 |
Why?
|
| Eczema | 1 | 2020 | 3 | 0.180 |
Why?
|
| Lipase | 1 | 2020 | 5 | 0.180 |
Why?
|
| Rhinitis, Allergic | 1 | 2020 | 10 | 0.180 |
Why?
|
| Phenotype | 2 | 2018 | 292 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2021 | 151 | 0.170 |
Why?
|
| Pancreas | 1 | 2020 | 29 | 0.170 |
Why?
|
| Dyslipidemias | 2 | 2019 | 17 | 0.170 |
Why?
|
| Food Hypersensitivity | 1 | 2020 | 40 | 0.170 |
Why?
|
| Neuropsychological Tests | 2 | 2021 | 1176 | 0.170 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 195 | 0.170 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2018 | 16 | 0.170 |
Why?
|
| Neoplasms | 2 | 2020 | 224 | 0.170 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 129 | 0.170 |
Why?
|
| Inbreeding Depression | 1 | 2019 | 3 | 0.170 |
Why?
|
| Consanguinity | 1 | 2019 | 5 | 0.170 |
Why?
|
| Fertility | 1 | 2019 | 16 | 0.170 |
Why?
|
| Autopsy | 1 | 2021 | 313 | 0.170 |
Why?
|
| Risk-Taking | 1 | 2019 | 22 | 0.170 |
Why?
|
| Cholesterol, HDL | 2 | 2016 | 25 | 0.160 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 36 | 0.160 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 4 | 0.160 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 39 | 0.160 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 277 | 0.160 |
Why?
|
| Comorbidity | 2 | 2020 | 457 | 0.160 |
Why?
|
| Asthma | 1 | 2020 | 134 | 0.150 |
Why?
|
| Androgens | 1 | 2018 | 8 | 0.150 |
Why?
|
| Lung Diseases | 1 | 2018 | 42 | 0.150 |
Why?
|
| Insulin Resistance | 2 | 2017 | 49 | 0.150 |
Why?
|
| Antioxidants | 1 | 2018 | 57 | 0.150 |
Why?
|
| Endocrine Disruptors | 1 | 2018 | 1 | 0.150 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 443 | 0.150 |
Why?
|
| Child Behavior | 1 | 2018 | 33 | 0.150 |
Why?
|
| Fluorocarbons | 1 | 2018 | 11 | 0.150 |
Why?
|
| Basal Metabolism | 1 | 2018 | 8 | 0.150 |
Why?
|
| Mother-Child Relations | 1 | 2018 | 31 | 0.150 |
Why?
|
| Testosterone | 1 | 2018 | 26 | 0.150 |
Why?
|
| Diet, Reducing | 1 | 2018 | 10 | 0.150 |
Why?
|
| Thiocyanates | 1 | 2017 | 2 | 0.150 |
Why?
|
| Perchlorates | 1 | 2017 | 5 | 0.150 |
Why?
|
| Nitrates | 1 | 2017 | 10 | 0.150 |
Why?
|
| Thyroid Function Tests | 1 | 2017 | 12 | 0.150 |
Why?
|
| Hospitalization | 1 | 2020 | 292 | 0.150 |
Why?
|
| Vascular Calcification | 1 | 2017 | 9 | 0.140 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2017 | 1 | 0.140 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2017 | 1 | 0.140 |
Why?
|
| Aspartate Aminotransferases | 1 | 2017 | 13 | 0.140 |
Why?
|
| Alanine Transaminase | 1 | 2017 | 14 | 0.140 |
Why?
|
| Protective Factors | 4 | 2018 | 27 | 0.140 |
Why?
|
| Health Personnel | 1 | 2018 | 102 | 0.140 |
Why?
|
| Fatty Liver | 1 | 2017 | 30 | 0.140 |
Why?
|
| Inhalation Exposure | 1 | 2016 | 4 | 0.140 |
Why?
|
| Transportation | 1 | 2016 | 5 | 0.140 |
Why?
|
| Pregnancy | 1 | 2018 | 291 | 0.140 |
Why?
|
| Histones | 1 | 2016 | 27 | 0.140 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2016 | 5 | 0.130 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 7 | 0.130 |
Why?
|
| Actigraphy | 1 | 2016 | 95 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2016 | 32 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2016 | 6 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 7 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2017 | 532 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 53 | 0.130 |
Why?
|
| Child, Preschool | 1 | 2018 | 640 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 847 | 0.130 |
Why?
|
| Waist-Height Ratio | 1 | 2015 | 6 | 0.130 |
Why?
|
| Cognition Disorders | 1 | 2022 | 965 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2016 | 69 | 0.120 |
Why?
|
| Cause of Death | 3 | 2022 | 63 | 0.120 |
Why?
|
| Health Behavior | 1 | 2016 | 136 | 0.120 |
Why?
|
| Sweating | 1 | 2014 | 2 | 0.120 |
Why?
|
| Hot Flashes | 1 | 2014 | 10 | 0.120 |
Why?
|
| Perimenopause | 1 | 2014 | 13 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 284 | 0.120 |
Why?
|
| Copper | 2 | 2024 | 18 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 472 | 0.110 |
Why?
|
| Risk | 3 | 2018 | 190 | 0.100 |
Why?
|
| Prognosis | 1 | 2015 | 739 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 299 | 0.100 |
Why?
|
| Age Factors | 3 | 2022 | 716 | 0.100 |
Why?
|
| Triglycerides | 2 | 2025 | 57 | 0.090 |
Why?
|
| Cholesterol | 2 | 2025 | 59 | 0.090 |
Why?
|
| Genotype | 2 | 2024 | 326 | 0.090 |
Why?
|
| Quantitative Trait Loci | 2 | 2021 | 39 | 0.090 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2021 | 2 | 0.080 |
Why?
|
| Educational Status | 2 | 2021 | 271 | 0.080 |
Why?
|
| Nutrition Surveys | 2 | 2018 | 19 | 0.080 |
Why?
|
| Walking | 2 | 2021 | 219 | 0.070 |
Why?
|
| Switzerland | 1 | 2024 | 7 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.060 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 311 | 0.060 |
Why?
|
| Tea | 1 | 2024 | 6 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2024 | 39 | 0.060 |
Why?
|
| Food Handling | 1 | 2024 | 2 | 0.060 |
Why?
|
| Fast Foods | 1 | 2024 | 5 | 0.060 |
Why?
|
| Zinc | 1 | 2024 | 41 | 0.060 |
Why?
|
| Heterozygote | 1 | 2025 | 91 | 0.060 |
Why?
|
| Energy Intake | 1 | 2024 | 72 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2024 | 87 | 0.060 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2023 | 12 | 0.050 |
Why?
|
| Caloric Restriction | 1 | 2023 | 16 | 0.050 |
Why?
|
| Tocopherols | 1 | 2023 | 9 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2023 | 13 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 13 | 0.050 |
Why?
|
| Hypertension | 1 | 2024 | 201 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 12 | 0.050 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 7 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2022 | 13 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 49 | 0.050 |
Why?
|
| Brain Infarction | 1 | 2023 | 71 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 93 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 8 | 0.050 |
Why?
|
| United Kingdom | 1 | 2022 | 52 | 0.050 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2022 | 63 | 0.050 |
Why?
|
| Vegetables | 1 | 2021 | 18 | 0.050 |
Why?
|
| Gene Expression | 1 | 2022 | 182 | 0.050 |
Why?
|
| Accelerometry | 1 | 2021 | 78 | 0.050 |
Why?
|
| Executive Function | 1 | 2021 | 98 | 0.050 |
Why?
|
| Music Therapy | 1 | 2020 | 5 | 0.050 |
Why?
|
| Intubation | 1 | 2020 | 6 | 0.040 |
Why?
|
| Meditation | 1 | 2020 | 22 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 17 | 0.040 |
Why?
|
| Homozygote | 1 | 2019 | 17 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 75 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 45 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 97 | 0.040 |
Why?
|
| Nursing Research | 1 | 2020 | 42 | 0.040 |
Why?
|
| Diastole | 1 | 2019 | 27 | 0.040 |
Why?
|
| ADAMTS9 Protein | 1 | 2018 | 1 | 0.040 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2018 | 2 | 0.040 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2018 | 2 | 0.040 |
Why?
|
| Lod Score | 1 | 2018 | 12 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 95 | 0.040 |
Why?
|
| Dehydroepiandrosterone | 1 | 2018 | 4 | 0.040 |
Why?
|
| Animals | 2 | 2016 | 3510 | 0.040 |
Why?
|
| Androstenedione | 1 | 2018 | 4 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 104 | 0.040 |
Why?
|
| Rest | 1 | 2018 | 26 | 0.040 |
Why?
|
| Symporters | 1 | 2017 | 7 | 0.040 |
Why?
|
| Life Tables | 1 | 2017 | 4 | 0.040 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2017 | 1 | 0.040 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2017 | 1 | 0.040 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2017 | 1 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 3 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2017 | 6 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 209 | 0.040 |
Why?
|
| RNA Interference | 1 | 2017 | 32 | 0.040 |
Why?
|
| Transfection | 1 | 2017 | 112 | 0.040 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 1 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 2 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 45 | 0.040 |
Why?
|
| Histone Code | 1 | 2016 | 1 | 0.030 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2016 | 2 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 26 | 0.030 |
Why?
|
| Bias | 1 | 2016 | 37 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 329 | 0.030 |
Why?
|
| Genome, Human | 1 | 2016 | 36 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 366 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 221 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 913 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 244 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 46 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 157 | 0.030 |
Why?
|
| Health | 1 | 2016 | 8 | 0.030 |
Why?
|
| Gardening | 1 | 2016 | 1 | 0.030 |
Why?
|
| Bicycling | 1 | 2016 | 3 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 66 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2016 | 96 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 134 | 0.030 |
Why?
|
| Arteries | 1 | 2016 | 14 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 140 | 0.030 |
Why?
|
| Cardiology | 1 | 2016 | 52 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 54 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 70 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2016 | 75 | 0.030 |
Why?
|
| Sports | 1 | 2016 | 53 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 167 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2016 | 166 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2014 | 3 | 0.030 |
Why?
|
| Anxiety | 1 | 2016 | 150 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 261 | 0.030 |
Why?
|
| Calcium | 1 | 2018 | 364 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 410 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 698 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 3231 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2016 | 776 | 0.020 |
Why?
|